Evidence map›Paper›PMID 40963220›Full record

ArticleJournal of chemical theory and computation2025

Introducing the Coupled-Cluster Theory to the Amorphous World of Liquids and Their Thermodynamic Simulations.

Ctirad Červinka

Abstract read
In one paragraph

Article in Journal of chemical theory and computation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ctirad ČervinkaDepartment of Physical Chemistry, University of Chemistry and Technology Prague, Technická 5, CZ-166 28 Prague 6, Czech Republic.ORCID 0000-0003-1498-6715

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amorphous molecular materials are ubiquitous, spanning drugs, semiconductors, or solvents. Large predictive capabilities of quantum-chemical simulations of structural and thermodynamic properties and phase transitions for such amorphous materials have remained out of reach for a long time due to the related immense computational costs. This work introduces a novel fragment-based ab initio Monte Carlo (FrAMonC) simulation technique to the amorphous realm of molecular liquids and glasses. It aims at enabling thermodynamic simulations for amorphous molecular materials based on direct ab initio sampling and at minimizing the amount of a priori required empirical inputs for such simulations. Focus on individual cohesive interactions within the bulk, and their sampling from multiple first-principles potentials with a many-body expansion scheme enables the use of very accurate electron-structure methods for the most important cohesive features within the material. Even the coupled-cluster theory, the direct use of which is unprecedented for molecular simulations of thermodynamic properties for liquids, then becomes applicable to the description of bulk amorphous materials. Its incorporation in the proposed Monte Carlo simulations promises very high computational accuracy. Bulk-phase equilibrium properties at finite temperatures and pressures, such as density and vaporization enthalpy, as well as response properties such as thermal expansivity and heat capacity that are particularly challenging to predict accurately, are the observables targeted in this work. Superior computational accuracy of the introduced FrAMonC simulations is demonstrated for most target properties (liquid-phase densities, thermal expansivities, and gas-liquid differences in the heat capacities) when compared with established classical or quantum-chemical models that are commonly used to model such properties of bulk liquids.

Identifiers

PMID40963220
PMCPMC12529918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.